Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the “funeral” of warfarin?

Journal of Interventional Cardiac Electrophysiology

Volumn 41, Issue 2, 2014, Pages 103-105

  Di Biase, Luigi ^a,b,c,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^c The University of Texas at Austin   (United States)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; RIVAROXABAN; WARFARIN;

BRAIN ISCHEMIA; CATHETER ABLATION; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; THROMBOEMBOLISM; ADVERSE EFFECTS; ATRIAL FIBRILLATION; NEEDS ASSESSMENT; ORAL DRUG ADMINISTRATION; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CATHETER ABLATION; HUMANS; NEEDS ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; WARFARIN;

EID: 84909999885     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-014-9944-5     Document Type: Editorial

References (17)

1. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y. H., Klein, G., Natale, A., Packer, D., & Skanes, A. (2009). Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. Journal of the American College of Cardiology, 53, 1798–1803.
2. Scherr, D., Sharma, K., Dalal, D., Spragg, D., Chilukuri, K., Cheng, A., Dong, J., Henrikson, C. A., Nazarian, S., Berger, R. D., Calkins, H., & Marine, J. E. (2009). Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 20, 1357–1363.
3. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y. H., Klein, G., Natale, A., Packer, D., Skanes, A., Ambrogi, F., & Biganzoli, E. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3, 32–38.
4. Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., Reddy, M., Hao, S., Hongo, R., Beheiry, S., Zagrodzky, J., Rong, B., Mohanty, S., Elayi, C. S., Forleo, G., Pelargonio, G., Narducci, M. L., Dello Russo, A., Casella, M., Fassini, G., Tondo, C., Schweikert, R. A., & Natale, A. (2014). Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation, 129, 2638–2644.
5. Di Biase, L., Gaita, F., Toso, E., Santangeli, P., Mohanty, P., Rutledge, N., Yan, X., Mohanty, S., Trivedi, C., Bai, R., Price, J., Horton, R., Gallinghouse, G. J., Beheiry, S., Zagrodzky, J., Canby, R., Leclercq, J. F., Halimi, F., Scaglione, M., Cesarani, F., Faletti, R., Sanchez, J., Burkhardt, J. D., & Natale, A. (2014). Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Heart Rhythm, 11, 791–798.
6. Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vanga, S. R., Santangeli, P., Swarup, V., Pimentel, R., Mansour, M. C., D’Avila, A., Sanchez, J. E., Burkhardt, J. D., Chalhoub, F., Mohanty, P., Coffey, J., Shaik, N., Monir, G., Reddy, V. Y., Ruskin, J., & Natale, A. (2012). Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 59, 1168–1174.
7. Kim, J. S., She, F., Jongnarangsin, K., Chugh, A., Latchamsetty, R., Ghanbari, H., Crawford, T., Suwanagool, A., Sinno, M., Carrigan, T., Kennedy, R., Saint-Phard, W., Yokokawa, M., Good, E., Bogun, F., Pelosi, F., Jr., Morady, F., & Oral, H. (2013). Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm, 10, 483–489.
8. Bassiouny, M., Saliba, W., Rickard, J., Shao, M., Sey, A., Diab, M., Martin, D. O., Hussein, A., Khoury, M., Abi-Saleh, B., Alam, S., Sengupta, J., Borek, P. P., Baranowski, B., Niebauer, M., Callahan, T., Varma, N., Chung, M., Tchou, P. J., Kanj, M., Dresing, T., Lindsay, B. D., & Wazni, O. (2013). Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 6, 460–466.
9. Stepanyan, G., Badhwar, N., Lee, R. J., Marcus, G. M., Lee, B. K., Tseng, Z. H., Vedantham, V., Olgin, J., Scheinman, M., & Gerstenfeld, E. P. (2014). Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology, 40, 33–38.
10. Kaiser, D. W., Streur, M. M., Nagarakanti, R., Whalen, S. P., & Ellis, C. R. (2013). Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter. Journal of Interventional Cardiac Electrophysiology, 37, 241–247.
11. Imamura, K., Yoshida, A., Takei, A., Fukuzawa, K., Kiuchi, K., Takami, K., Takami, M., Itoh, M., Fujiwara, R., Suzuki, A., Nakanishi, T., Yamashita, S., Matsumoto, A., & Hirata, K. (2013). Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay. Journal of Interventional Cardiac Electrophysiology, 37, 223–231.
12. Sardar, P., Nairooz, R., Chatterjee, S., Wetterslev, J., Ghosh, J., & Aronow, W. S. (2014). Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. American Journal of Cardiology, 113, 1173–1177.
13. Steinberg, B. A., Hasselblad, V., Atwater, B. D., Bahnson, T. D., Washam, J. B., Alexander, J. H., Daubert, J. P., & Piccini, J. P. (2013). Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies. Journal of Interventional Cardiac Electrophysiology, 37, 213–221.
14. Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., Gangireddy, S., Swarup, V., Chalhoub, F., Atkins, D., Bommana, S., Verma, A., Sanchez, J. E., Burkhardt, J. D., Barrett, C. D., Baheiry, S., Ruskin, J., Reddy, V., & Natale, A. (2014). Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. Journal of the American College of Cardiology, 63, 982–988.
15. Di Biase, L., Burkhardt, J.D., Mohanty, P., Trivedi, C., Mohanty, S., Santangeli, P., Bai, R., Sanchez, J., Horton, R., Gallinghouse, G.J., Hongo, R.H., Beheiry, S., Hao, S.C., Bailey, S., Al-Ahmad, A., Hranitzky, P., Reddy, M., Lakkireddy, D.R., Viles-Gonzalez, J.F., Rutledge, N., Natale, A. (2014). Uninterrupted apixaban administration during ablation of non paroxysmal atrial fibrillation feasibility and safety. Heart Rhythm, 11(S5):S200 [PO02-95].
16. Naccarelli, G.V., Cappato, R., Hohnloser, S.H., Marchlinski, F.E, Wilber, D.J, Xiang, J., Ma, C., Hess, S., Davies, D.W., Fields, L.E, & Natale A; on behalf of the VENTURE-AF Investigators (2014). Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology.
17. Witt, D. M., Delate, T., Clark, N. P., Garcia, D. A., Hylek, E. M., Ageno, W., Dentali, F., & Crowther, M. A. (2013). Nonadherence with INR monitoring and anticoagulant complications. Thrombosis Research, 132, e124–e130.